Keywords: bausch, lomb, licenses, anti-angiogenesis, drugs, ptc, eye

Bausch & Lomb licenses anti-angiogenesis drugs from PTC

Article | 05 December 2005

Eye care giant Bausch & Lomb has licensed several anti-angiogenesis compounds as ophthalmology product candidates from PTC Therapeutics, a fellow US, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Bausch & Lomb

Go to company listing